• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: C.R. BARD, INC. (GFO) LUTONIX 035 DRUG COATED BALLOON PTA CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

C.R. BARD, INC. (GFO) LUTONIX 035 DRUG COATED BALLOON PTA CATHETER Back to Search Results
Model Number 9004
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Gangrene (1873)
Date of Event 04/28/2015
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Analysis: the sample(s) were not returned to the user facility; therefore, evaluations of the actual samples are unable to be performed.A lot history review revealed this is the only similar complaint associated with this lot.A review of the device history record (dhr) shows the lot was manufactured to specification.Conclusion: the actual samples were not received for evaluation.The dhr found nothing to indicate a manufacturing related cause for this event.The investigator assessed the event was possibly related to the study device, drug or procedure.Based on the patient's presenting medical condition prior to the angioplasty procedure, it is unlikely the lutonix dcb's caused or contributed to the events.If additional information becomes known to the manufacturer, a supplemental report will be provided will all relevant information.The information provided by bard represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bard.
 
Event or Problem Description
It was reported that prior to the index procedure, allegedly the patient had a "purulent nail bed inflammation and periungual necrosis of the first toe left side" at the time of enrollment and the index procedure.Treatment with antibiotics, tavanic, was started during the index procedure admission.The patient was then treated with three lutonix percutaneous transluminal drug coated balloon (dcb) dilatation catheter.Reportedly, a few months later the patient's first toe left side of the target limb became inflamed from the pre-existing infected skin ulcer.The patient was hospitalized and reportedly an amputation was performed due to progressive gangrene of the left forefoot.The cec adjudicated the event as possibly related to the study device, drug or procedure.The sample was discarded by the user facility and not available for further evaluation.No adverse patient effects were reported.This is one of three products involved with the reported event and are associated manufacturers report numbers 3006513822-2016-00057 and 3006513822-2016-00058.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LUTONIX 035 DRUG COATED BALLOON PTA CATHETER
Common Device Name
DRUG COATED BALLOON PTA CATHETER
Manufacturer (Section D)
C.R. BARD, INC. (GFO)
289 bay road
queensbury NY 12804
MDR Report Key5510912
Report Number3006513822-2016-00059
Device Sequence Number395094
Product Code ONU
UDI-Device Identifier00801741088582
UDI-Public(01)00801741088582(17)151030(10)GFXJ0720
Combination Product (Y/N)N
Initial Reporter CountryAU
PMA/510(K) Number
P130024
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source health professional,other,stu
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 03/01/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date10/30/2015
Device Model Number9004
Device Catalogue Number9004400063
Device Lot NumberGFXJ0720
Was Device Available for Evaluation? No
Event Location Hospital
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer Not provided
Initial Report FDA Received Date03/18/2016
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient Age67 YR
Patient Weight81
-
-